SQI Diagnostics, Inc.

SQI Diagnostics, Inc.

Sector: In Vitro And In Vivo Diagnostic Substances Region: Canada

: | TSX Venture Exchange: SQD | OTC Markets: SQIDF

Similar to: Abcam Plc, Sartorius Stedim Biotech SA, Chembio Diagnostics, Inc.

SQI Diagnostics, Inc. is a life sciences company, which develops and commercializes proprietary technologies and products for advanced microarray diagnostics. The company provides laboratories the ability to simultaneously analyze multiple biomarkers, deliver accurate patient results in less time, significantly reduce labor, and increase profits. It is engaged in three principal and integrated lines of business which include Diagnostics Tools and services including microarray printing, design, and test development to enable customers to multiplex their content, Instruments designed to provide various levels of automation, product development software, and configurable workflow management to meet application and throughput requirements and Multiplexed IVD products targeting protein and antibody biomarkers in autoimmune and other immunology markets. SQI Diagnostics was founded by Peter Lea in 1999 and is headquartered in Toronto, Canada.

News & Analysis

You may also be interested in: